PlantEXT

Cannabis-based Anti-inflammatory Products

Health Tech & Life Sciences
Active
Seed Herzliya, Israel Founded 2015
Last updated 2026-06-18
Total raised
$5.6M
Last: 2019-04
Stage
Seed
Founded
2015
Headcount
7
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

PlantEXT is discovering and developing active cannabis extracts with a focus on anti-inflammatory remedies.

PlantEXT's technology isolates therapeutic elements at the molecular level and quantifies anti-inflammatory activity through in-vitro and ex-vivo studies. The company's team has developed a pipeline of anti-inflammatory products supported by pre-clinical and clinical research. The company is currently launching its first line of IBD medical cannabis products in Israel and will follow with its international expansion and the launch of further medical products for additional indications such as psoriasis, atopic dermatitis, arthritis, pain, and migraines.

The company has a research agreement with the agricultural research organization Volcani Center and the exclusive rights to commercialize the results and products worldwide.

Funding history · 3 rounds · $5.6M total

2019-04
$1.2M
2018-04
$2.4M
2018-02
$2.0M

Q&A

What is PlantEXT's primary focus?
PlantEXT is discovering and developing active cannabis extracts, with a primary focus on anti-inflammatory remedies.
Where is PlantEXT headquartered?
PlantEXT is headquartered in Herzliya, Israel.
What is PlantEXT's total funding to date?
PlantEXT has raised a total of $5.6 million USD.
When was PlantEXT founded?
PlantEXT was founded in December 2015.
What is PlantEXT's current product stage?
PlantEXT's products are in the clinical trial stage.
Does PlantEXT have any research agreements?
Yes, PlantEXT has a research agreement with the agricultural research organization Volcani Center and holds exclusive worldwide commercialization rights to the results and products.
What types of products is PlantEXT developing?
PlantEXT is developing a pipeline of anti-inflammatory products, including a line of IBD medical cannabis products for launch in Israel, and future products for indications such as psoriasis, atopic dermatitis, arthritis, pain, and migraines.

Team · 1

Founder · Founder & President (Israel)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsMoleculesHerbals
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalstherapeuticsmedical-cannabispain-reliefchronic-patientstopical-treatmentcannabisanti-inflammatorydermatologypatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)